A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/14 (2006.01) A61K 9/20 (2006.01) A61K 31/277 (2006.01)
Patent
CA 2366747
This invention relates to a controlled or sustained release formulation designed to deliver a PDE4 inhibitor for treating an inflammatory disease such as asthma or COPD and the like.
L'invention concerne une préparation à libération contrôlée ou soutenue destinée à administrer un inhibiteur PDE4 en vue de traiter une maladie inflammatoire telle que l'asthme ou la BPCO et les maladies similaires.
Faulkner Patrick G.
Lucca Jaime J.
Wrzosek Thomas J.
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Controlled release formulation for treating copd does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release formulation for treating copd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation for treating copd will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1517831